Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
43 hedge funds and large institutions have $127M invested in Neos Therapeutics, Inc in 2015 Q3 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
+$20M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$19.6M |
| 3 |
SCM
Sio Capital Management
New York
|
+$14.7M |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
+$13.5M |
| 5 |
DM
Deerfield Management
New York
|
+$10.1M |
Top Sellers
NEOS Hedge Fund Activity: Q3 2015 in Review
43 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q3 2015, worth a combined $127M.
Buyers outnumbered sellers: 43 funds opened new NEOS positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was DSC Advisors, opening a new position worth an estimated $20M.
- 43 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $127M of Neos Therapeutics, Inc stock for Q3 2015.
- 43 funds opened new Neos Therapeutics, Inc positions in Q3 2015 and 0 closed out, a net change of +43 holders.
- The largest Neos Therapeutics, Inc buyer in Q3 2015 was DSC Advisors, an estimated $20M added.
Based on aggregated 13F filings for Q3 2015.